Ortiv-Q3 Research Profile
Key Indicators
- Authorised Capital ₹ 2.30 Cr
- Paid Up Capital ₹ 1.75 Cr
- Company Age 6 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 119.48%
- Profit Growth 95.18%
- Ebitda 2156.43%
- Net Worth -2.28%
- Total Assets -2.20%
About Ortiv-Q3 Research
Ortiv-Q3 Research Private Limited (ORPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 January 2019 (Six years 16 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.30 Cr and a paid-up capital of Rs 1.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ortiv-Q3 Research Private Limited India is Ashish Gupta as CEO. Ramaswamy Lakshmanan, Pawan Gupta, Mukesh Kumar, and Three other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100GJ2019PTC106368
-
Company No.
106368
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jan 2019
-
Date of AGM
16 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Ortiv-Q3 Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Gupta | CEO | 24-Aug-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Haddouchi
|
Director | 01-Jul-2021 | Current |
Mukesh Kumar
|
Director | 31-Jan-2019 | Current |
|
Ramaswamy Lakshmanan
|
Nominee Director | 20-Apr-2021 | Current |
|
Pawan Gupta
|
Director | 31-Jan-2019 | Current |
Lukas Bruttel
|
Director | 04-Jun-2021 | Current |
|
Ashish Gupta
|
Director | 08-Sep-2021 | Current |
Financial Performance of Ortiv-Q3 Research.
Ortiv-Q3 Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 119.48% increase. The company also saw a substantial improvement in profitability, with a 95.18% increase in profit. The company's net worth dipped by a decrease of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ortiv-Q3 Research?
In 2023, Ortiv-Q3 Research had a promoter holding of 85.01% and a public holding of 14.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sotax India Private LimitedRamaswamy Lakshmanan is a mutual person
-
Evakenko Wellness Private Limited
Pawan Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ortiv-Q3 Research?
Ortiv-Q3 Research has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ortiv-Q3 Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ortiv-Q3 Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
